Ted White's most recent trade in Verrica Pharmaceuticals Inc was a trade of 24,979 Common Stock done at an average price of $2.7 . Disclosure was reported to the exchange on Aug. 26, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Verrica Pharmaceuticals Inc | Ted White | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 2.66 per share. | 26 Aug 2024 | 24,979 | 224,988 (0%) | 0% | 2.7 | 66,444 | Common Stock |
| Verrica Pharmaceuticals Inc | Ted White | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 2.46 per share. | 26 Aug 2024 | 9,021 | 215,967 (0%) | 0% | 2.5 | 22,192 | Common Stock |
| Verrica Pharmaceuticals Inc | Ted White | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 7.06 per share. | 22 Jul 2024 | 32,469 | 250,121 (0%) | 0% | 7.1 | 229,231 | Common Stock |
| Verrica Pharmaceuticals Inc | Ted White | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 6.98 per share. | 22 Jul 2024 | 154 | 249,967 (0%) | 0% | 7.0 | 1,075 | Common Stock |
| Verrica Pharmaceuticals Inc | Ted White | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 225,000 | 225,000 | - | - | Employee Stock Option (right to buy) | |
| Verrica Pharmaceuticals Inc | Ted White | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 112,500 | 282,590 (1%) | 0% | 0 | Common Stock | |
| Clear Channel Outdoor Hold... | Ted Raymond White | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 80,213 | 80,213 (0%) | 0% | 0 | Common Stock | |
| Clear Channel Outdoor Hold... | White Ted Raymond | Director | Grant, award, or other acquisition of securities at price $ 1.87 per share. | 15 Feb 2024 | 48,128 | 128,341 (0%) | 0% | 1.9 | 89,999 | Common Stock |
| Verrica Pharmaceuticals Inc | Ted White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.93 per share. | 14 Nov 2023 | 22,141 | 181,648 (0%) | 0% | 2.9 | 64,873 | Common Stock |
| Verrica Pharmaceuticals Inc | Ted White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.97 per share. | 14 Nov 2023 | 11,558 | 170,090 (0%) | 0% | 3.0 | 34,327 | Common Stock |
| Verrica Pharmaceuticals Inc | Ted White | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2023 | 150,000 | 278,789 (1%) | 0% | 0 | Common Stock | |
| Verrica Pharmaceuticals Inc | Ted White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2023 | 75,000 | 203,789 (0%) | 0% | 0 | Common Stock | |
| Verrica Pharmaceuticals Inc | Ted White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 150,000 | 179,466 (0%) | 0% | 0 | Common Stock | |
| Verrica Pharmaceuticals Inc | Ted White | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.83 per share. | 21 Jul 2023 | 50,677 | 128,789 (0%) | 0% | 4.8 | 244,770 | Common Stock |
| Verrica Pharmaceuticals Inc | Ted White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 240,000 | 240,000 | - | - | Employee Stock Option (right to buy) | |
| Verrica Pharmaceuticals Inc | Ted White | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.10 per share. | 05 Jul 2022 | 7,500 | 29,466 (0%) | 0% | 2.1 | 15,750 | Common Stock |
| Verrica Pharmaceuticals Inc | Ted White | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 9.95 per share. | 04 Jun 2021 | 4,000 | 21,966 (0%) | 0% | 10.0 | 39,800 | Common Stock |
| Verrica Pharmaceuticals Inc | Ted White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 160,000 | 160,000 | - | - | Employee Stock Option (Right to Buy) |